Search - tctmd.com

Displaying 1 - 20 of 115

Sort: Relevancy | Date

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

Year in Review: Top Prevention Stories of 2025

News Daily News

Year in Review: Top Prevention Stories of 2025

Michael O'Riordan

December 24, 2025

Cardiac Damage Starts Early When There’s Family History of Cardiometabolic Disease

News Daily News

Cardiac Damage Starts Early When There’s Family History of Cardiometabolic Disease

December 18, 2025

Healthcare Expenses Increase After GLP-1 Prescription

News Daily News

Healthcare Expenses Increase After GLP-1 Prescription

August 18, 2025

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

July 24, 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

March 29, 2025

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

News Daily News

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

February 26, 2025

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

News Daily News

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

January 10, 2025

Top General Cardiology and Prevention News of 2024

News Daily News

Top General Cardiology and Prevention News of 2024

December 30, 2024

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

News Daily News

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

November 13, 2024

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

News Daily News

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

Michael O'Riordan

October 03, 2024

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

News Daily News

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Michael O'Riordan

August 21, 2024

Semaglutide May Ease Tobacco Use, Study Suggests

News Daily News

Semaglutide May Ease Tobacco Use, Study Suggests

August 01, 2024

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

May 17, 2024

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks

News Daily News

GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks

January 21, 2024

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

News Daily News

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

January 12, 2024

No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA

News Daily News

No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA

Michael O'Riordan

January 05, 2024

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.